The relevance of the stimulation of 5-aminolaevulinate synthetase to the accumulation of cytochrome P-450 after administration of drugs was examined in rats treated with phenylbutazone and with 3,5-diethoxycarbonyl-1,4-dihydrocollidine. 3,5-Diethoxycarbonyl-1,4-dihydrocollidine alone stimulated 5-aminolaevulinate synthetase without increasing the concentration of cytochrome P-450, whereas phenylbutazone alone increased the microsomal cytochrome P-450 without significantly affecting the activity of the enzyme. When the two drugs were given together both effects were found. It is concluded that if an increased amount of 5-aminolaevulinate and haem must be made to provide for the accumulation of cytochrome P-450, it need only be a small amount. It is also concluded from these findings that stimulation of the drug-metabolizing system on the one hand and marked enhancement of 5-aminolaevulinate synthetase activity and porphyria on the other are likely to result from different actions of the drugs. Evidence is presented suggesting that porphyrogenic drugs stimulate markedly the activity of 5-aminolaevulinate synthetase by lowering the concentration of haem in the liver, thereby decreasing the normal feedback control. With 3,5-diethoxycarbonyl-1,4-dihydrocollidine a rapid inhibition of mitochondrial ferrochelatase and of liver haem synthesis may be the primary mechanism involved.
The relevance of the stimulation of 5-aminolaevulinate synthetase to the accumulation of cytochrome P-450 after administration of drugs was examined in rats treated with phenylbutazone and with 3,5-diethoxycarbonyl-1,4-dihydrocollidine. 3,5-Diethoxycarbonyl-1,4-dihydrocollidine alone stimulated 5-aminolaevulinate synthetase without increasing the concentration of cytochrome P-450, whereas phenylbutazone alone increased the microsomal cytochrome P-450 without significantly affecting the activity of the enzyme. When the two drugs were given together both effects were found. It is concluded that if an increased amount of 5-aminolaevulinate and haem must be made to provide for the accumulation of cytochrome P-450, it need only be a small amount. It is also concluded from these findings that stimulation of the drug-metabolizing system on the one hand and marked enhancement of 5-aminolaevulinate synthetase activity and porphyria on the other are likely to result from different actions of the drugs. Evidence is presented suggesting that porphyrogenic drugs stimulate markedly the activity of 5-aminolaevulinate synthetase by lowering the concentration of haem in the liver, thereby decreasing the normal feedback control. With 3,5-diethoxycarbonyl-1,4-dihydrocollidine a rapid inhibition of mitochondrial ferrochelatase and of liver haem synthesis may be the primary mechanism involved.
Several chemically unrelated drugs cause hepatic porphyria in animals and stimulate the formation of porphyrins by liver cells cultured in vitro (De Matteis, 1967 , 1971a .
There are a number of similarities between druginduced porphyria and stimulation of drug-metabolizing enzymes. In both effects: (1) drugs act directly on liver cells and not through hormones; (2) several chemically unrelated drugs are equally effective; (3) lipid solubility is an important property of effective drugs; (4) the metabolic change can be prevented by inhibitors of protein synthesis and by glucose. An increase in the microsomal cytochrome P-450 accompanies the stimulation of drug-metabolizing enzymes and this may require increased haem synthesis and enhanced activity of 5-aminolaevulinate synthetase, the rate-limiting enzyme of the haem-biosynthetic pathway (Granick, 1966) . Granick & Urata (1963) have found that the activity of this enzyme increases in the liver of animals made porphyric by drugs and Granick (1966) has suggested that the increase in microsomal cytochrome P450 and stimulation of 5-aminolaevulinate synthetase observed after drugs may be two aspects of the same response of the liver cell to detoxify foreign compounds. Vol. 126 Experiments have now been carried out in rats after treatment with drugs to find out whether increased activity of the haem-biosynthetic pathway and porphyria on the one hand, and increase in microsomal cytochrome P-450 on the other, are closely related phenomena and can be regarded as resulting from a single action of the drugs. Some of the findings have been given in a preliminary form at the International Conference on the Porphyrias, Cape Town (De Matteis, 1971a) .
Materials and Methods

Treatment ofanimals
Male albino rats of the Porton strain (150-180g) were either killed at different times after a single dose of drugs or given two daily doses for 2 or 3 days and killed 17h after the last dose. Finely powdered phenylbutazone (4-n-butyl-1,2-diphenyl-3,5-dioxopyrazolidine) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine were suspended in arachis oil and given by stomach tube. Control animals received the same volume of arachis oil. In the labelling experiment in vivo rats were starved for 24h, then dosed with 3,5- (1971b) . Mitochondria for porphyrin-metal chelatase assay and for porphyrin determination were obtained in 0.25M-sucrose as described by Jones & Jones (1969) , washed once and resuspended in 0.25M-sucrose. The microsomal fraction was obtained, washed and resuspended in 0.1 M-sodium phosphate buffer, pH7.4, as described by Bond & De Matteis (1969) .
Determination of microsomal cytochromes and protohaem
The microsomal cytochromes were determined as previously described (Bond & De Matteis, 1969) by using a Unicam SP. 800 recording spectrophotometer. The total protohaem content of the washed microsomal fraction was determined as described by De Matteis (1971b).
Enzyme assays 5-Aminolaevulinate synthetase was assayed by using washed mitochondria as the source of the enzyme (De Matteis, 1971b) . 5-Aminolaevulinate dehydratase (EC 4.2.1.24) was assayed as described by Gibson et al. (1955) with the difference that a sample of the deproteinized supernatant (0.5ml) was mixed with 1 ml ofwater and 1.5ml ofEhrlich reagent, 2M with respect to HC104 (Mauzerall & Granick, 1956) ; the E555 was determined between 15 and 25min after addition of Ehrlich reagent and a molar extinction coefficient of61 000 (Mauzerall & Granick, 1956) used to calculate the amount of porphobilinogen present.
Porphyrin-metal chelatase was determined, with mesoporphyrin and Co2+ as substrates, by the spectrophotometric method developed by Jones & Jones (1969) , except that the decrease in extinction ofband IV of the porphyrin was followed by scanning the spectrum from 520 to 490nm repeatedly, every 30-60s, in a Unicam SP. 800 spectrophotometer connected to a scale-expander. Mesoporphyrin (lOOnmol) and mitochondria (5-8mg of protein) in 2.75 ml of200mM-tris-HCl buffer, pH8.2, containing 0.074% Tween 80, were incubated at 30°C in the presence of CoCl2 (lOOnmol) .
For assay of aniline hydroxylase and nitroanisole demethylase activities washed microsomal fractions (4.5-6mg of protein) were incubated at 38°C with shaking (120 double oscillations/min) in an atmosphere of 02. Each flask contained, in a total volume of 3 ml, the following components (final concentrations in parentheses): KCI (66.6mM); sodium phosphate buffer (66.6mM); MgCl2 (14.0mM); glucose 6-phosphate (4.5mM); NADP (0.19mM); glucose 6-phosphate dehydrogenase (0.5 unit/flask); as substrate, aniline (10mM) or o-nitroanisole (3.33mM). Incubation time was 10min for aniline hydroxylase assay and 20min for nitroanisole demethylase assay at a pH of 7.4 and 7.9 respectively. The o-nitrophenol and 4-aminophenol produced during the incubation were determined as described by Gilbert & Golberg (1965) .
Haem synthesis in vitro
This was followed by measuring the incorporation of s9Fe into haem by liver homogenates or by liver slices. Liver homogenates (10%, w/v) in 0.25M-sucrose (4ml) or 400mg of liver slices were incubated in air at 38°C with shaking (100 cycles/min) in the presence of 500,umol of sodium phosphate-potassium phosphate buffer, pH7.4, or of Krebs-Ringer phosphate solution, pH7.4 (Umbreit et al., 1959) respectively, in a total volume of Sml. After a preliminary incubation of2min approx. 0.5,uCi of [59Fe]-ferric citrate was added and the incubation continued for a further lSmin. For liver slices the preliminary incubation was of 10min and the incubation mixture contained also 30nmol ofunlabelled ferrous sulphate.
After addition of horse erythrocyte lysate (to provide carrier haem) haemin was crystallized by the method of Labbe & Nishida (1957) . The dry crystals ofhaemin were dissolved in pyridine, the solution was filtered, a small sample taken for measurement of haem as the pyridine haemochrome and the remainder counted for radioactivity in a Packard Autogamma scintillation spectrometer. No change in specific radioactivity was observed after recrystallization of haemin from either experimental or control samples. A similar method was followed for the isolation of haemin from the liver of the rats injected with 59Fe.
Analytical methods ProteinsweredeterminedeitherbyAldridge's(1962) modification of the method of Robinson & Hogden (1940) , or as described by Lowry et aL (1951) with crystalline bovine albumin as the standard. Isolated haem was determined as the pyridine haemochrome by the method of Rimington (1942) . Porphyrins were extracted from total liver homogenates or from the mitochondrial fraction into 0.9M-HC104-ethanol (1:1, v/v) and measured fluorimetrically with protoporphyrin as the standard (Abbritti & De Matteis, 1971-72 
Calculation of results
Results are expressed as the arithmetic means± S.E.M. and the means compared by Student's t test (Fisher, 1934) . To obtain the value of P, a degree of freedom N1 +N2 -2 has been used throughout.
Results
In the present experiments two drugs were used: 3,5 -diethoxycarbonyl -1,4 -dihydrocollidine and phenylbutazone. They were chosen because the former had been previously found to stimulate porphyrin production by liver cells cultured in vitro at the concentration of 1 IM, whereas phenylbutazone had been found to be inactive in that system up to the highest concentration employed, 0.2mM (Granick, 1966; De Matteis, 1971a) , but it had been reported to stimulate the activity of drug-metabolizing enzymes in the liver of the rat (Conney et al., 1960 3,5-Diethoxycarbonyl-1,4-dihydrocollidine (200mg)+phenylbutazone (150mg) 4.86± 0.1 (10)** 818.4 ± 16.2 (6)** 24.0 ± 0.7 (6)* 38.7 ± 3.0 (6)* 17.4 ± 0.5 (6) 5.30± 1.35 (4)* synthetase without increasing the concentration of cytochromeP-450, whereas phenylbutazone increased the microsomal cytochrome without affecting the activity of the enzyme. When the two drugs were administered simultaneously both effects were observed. Phenylbutazone also increased the size of the liver and the protein content of the total liver as well as the protein content of the microsomal fraction (per g of wet liver; Table 1 ). Similar results were obtained for microsomal cytochrome P-450 content after 3 days of treatment, when an increased concentration of cytochrome bs was also observed after phenylbutazone administration.
The activity of two drug-metabolizing enzymes behaved as did cytochrome P-450 concentration (Table 2 ) and the porphyrin content of the total liver paralleled the activity of 5-aminolaevulinate synthetase (Table 3) .
The mitochondrial fraction from the livers of rats given both drugs together exhibited a pink discolouration after 2-3 days of treatment. This was found to be associated with an accumulation of porphyrins in amounts greater than observed after administration of 3,5-diethoxycarbonyl-1,4-dihydrocollidine alone (Table 3 ). The finding of higher concentrations of liver porphyrins (Table 3) suggested that a greater degree of porphyria could be obtained by both drugs together than by 3,5-diethoxycarbonyl-1,4-dihydrocollidine alone.
This was confirmed in rats killed at different times after a single dose of drugs; here again phenylbutazone increased cytochrome P-450 without causing a significant stimulation of 5-aminolaevulinate synthetase (not even at doses fourfold those effective on cytochrome P-450), whereas 3,5-diethoxycarbonyl-1,4-dihydrocollidine stimulated the enzyme without increasing the concentration of the cytochrome; administration of both drugs resulted in both effects and in a greater stimulation of enzyme activity than was observed after 3,5-diethoxycarbonyl-1 ,4-di- Table 2 . Effect of treatment of rats with 3,5-diethoxycarbonyl-1,4-dihydrocollidine or phenylbutazone or both for 2 days on the activity ofo-nitroanisole demethylase and ofaniline hydroxylase ofthe isolated microsomalfraction Rats were treated as indicated in the legend to (Table 4 and Fig. 1) . A rise in enzyme activity was already evident 2.5 h after dosing with the latter drug, whereas most of the cytochrome P-450 increase caused by phenylbutazone took place between 13 and 24h, at the time when the 5-aminolaevulinate synthetase activity was returning to normal values. A transient decline in cytochrome P-450 concentration was observed at 5 h after administration of 3,5-diethoxycarbonyl-1,4-dihydrocollidine either alone or together with phenylbutazone, coincidental with the rise in activity of 5-aminolaevulinate synthetase (Fig. 1) . The changes in concentration of cytochrome P-450 were statistically significant as compared with appropriate controls, also when expressed as nmol/mg of microsomal protein.
The total haem content of the washed microsomal fraction was also measured and compared with the concentration of microsomal cytochromes. The changes in microsomal P-450 content observed after administration of drugs were reflected in similar changes in the total haem content and this applied to both the transient fall observed at 5 h and the late increase observed after phenylbutazone treatment.
Effect ofdrug administration on the 5-aminolaevulinate concentration and 5-aminolaevulinate dehydratase activity of the liver
The 5-aminolaevulinate dehydratase activity was measured 5 and 13 h after a single dose of drugs (Table 5 ). The only significant change was observed Vol. 126 at 13h in rats given 3,5-diethoxycarbonyl-1,4-dihydrocollidine and phenylbutazone together, which showed an activity nearly twice the control value. Table 5 shows that this treatment also markedly raised the concentration of 5-aminolaevulinate in the liver; this finding is noteworthy in view of the correlation between liver concentrations of 5-aminolaevulinate and liver activity of 5-aminolaevulinate dehydratase, which has been reported after administration of 5-aminolaevulinate to the mouse (Onisawa & Labbe, 1962) .
Effect of drug administration on the incorporation of 59Fe into liver haem in vitro and in vivo
The incorporation of 59Fe into haem in vitro was studied by using liver preparations from rats given a dose of drugs 5 or 17h before killing. Liver homogenates were usually employed; in one experiment liver slices were used.
At both 5 and 17h after a single dose of drugs it was found that 3,5-diethoxycarbonyl-1,4-dihydrocollidine given either on its own or together with phenylbutazone greatly stimulated the incorporation of 59Fe into haem by liver slices, whereas phenylbutazone did so only slightly (Table 6 ). As observed for 5-aminolaevulinate synthetase and for 5-aminolaevulinate dehydratase the effect of the two drugs given together was greater than the effect of 3,5-diethoxycarbonyl-1,4-dihydrocollidine alone.
In the experiments described in Table 6 the rate of haem synthesis in vitro was studied by measuring the incorporation of "9Fe into the protoporphyrin present as such in the liver or generated endogenously during the incubation. Under these conditions the increased incorporation of "9Fe caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine could be due either to a stimulation of the activity of the chelatase (i.e. the enzyme that chelates iron into protoporphyrin to produce haem) or to an increased production of the protoporphyrin substrate. To distinguish between these two possibilities further experiments were carried out on liver homogenates from animals given a single dose of 3,5-diethoxycarbonyl-1,4-dihydrocollidine in oil or oil alone 5h before killing. When the incorporation of "9Fe into haem was studied in the presence of increasing concentrations of exogenous 5-aminolaevulinate or protoporphyrin, it was found that porphyric and control homogenates behaved in quite a different fashion (Fig. 2 and Table   7 ). With homogenates from porphyric animals the addition of either 5-aminolaevulinate or protoporphyrin did not produce great changes in the incorporation rate of 59Fe into haem. The incorporation rate of control homogenates was, on the contrary, very sensitive to the addition of either substrate: a threefold stimulation was observed with 5-aminolaevulinate and an even greater stimulation was obtained after addition of protoporphyrin, when incorporation far greater than the maximum observed with porphyric livers was obtained. Therefore the effect of 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment on the incorporation of s9Fe into haem in vitro was found to depend on whether exogenous protoporphyrin was added to the liver homogenate or not (Table 8 ). In the absence of exogenous protoporphyrin, 3,5-diethoxycarbonyl-1 ,4-dihydrocollidine treatment stimulated the incorporation of 59Fe into haem above the value of the corresponding controls, probably on account of the increased amount of protoporphyrin already present in the liver or generated during the incubation because of the porphyric state; in the presence of saturating amounts of protoporphyrin added from the outside (i.e. under conditions where the incorporation rate is mostly, if not entirely, dependent on the activity of the chelatase) treatment with 3,5-diethoxycarbonyl-1,4-dihydrocollidine inhibited the incorporation of "9Fe into haem.
This latter finding suggested that the activity of the chelatase enzyme was inhibited in porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Measurement of the chelatase activity by another method (Jones & Jones, 1969) , in mitochondria isolated 1 or 5h after a single dose of drugs, showed that this was indeed the case (Table 9 ); a significant inhibition was observed as early as 1 h after dosing with 3,5-diethoxycarbonyl-1 ,4-dihydrocollidine and by 5 h the degree of inhibition (67 %) was virtually identical with that found by the s9Fe method (68 %). Tables 7 and 8 also show that phenylbutazone did not inhibit chelatase activity and that when the two drugs were given together the inhibition observed (58 % with either method) was slightly less than with 3,5-diethoxycarbonyl-1,4-dihydrocollidine alone.
Since the chelatase is located inside the inner membrane of the mitochondrion (Jones & Jones, 1969) the possibility was considered that 3,5-diethoxycarbonyl-1,4-dihydrocollidine might inhibit the access of the porphyrin substrate to the enzymic site, giving rise to an apparent decrease in chelatase activity. This appears to be unlikely, however, as this effect of the drug could not be abolished by either exposing the mitochondria to ultrasound treatment or by doubling the concentration of detergent in the spectrophotometric assay of the chelatase.
When the incorporation of"9Fe into liver haem was measured in vivo after treatment with 3,5-diethoxy-1972 Table 7 .
Discussion
Synthesis of liver haem and control of cytochrome P-450 formation Several drugs such as phenobarbitone and benzpyrene when administered to the rat raise the concentration of cytochrome P-450 in the liver microsomal fraction (Conney, 1967) . Marver (1969) and Baron & Tephly (1969a , 1970 have reported that a severalfold increase in both activity of 5-aminolaevulinate synthetase and rate of liver haem synthesis precedes the increase in cytochrome P-450 after either phenobarbitone or benzpyrene treatment. Baron & Tephly (1969b) have also reported that the accumulation of cytochrome P-450 caused by phenobarbitone in rat liver can be prevented by administration of large doses of 3-amino-1,2,4-triazole, an inhibitor of hepatic haem synthesis. These findings have all been interpreted to indicate that an increased supply of haem is the primary event leading to the accumulation of the microsomal haemoprotein (Baron & Tephly, 1970) . The role of haem in this proposed mechanism would be similar to that claimed for haem in controlling and stimulating the formation of haemoglobin by reticulocytes (London et al., 1964) and embryonic erythroid cells (Wilt, 1965; Levere & Granick, 1967; Wainwright & Wainwright, 1966) .
There are several reasons why this interpretation should be viewed with caution. First, the results obtained by Baron & Tephly (1969b) with 3-amino-1,2,4-triazole may merely indicate that haem, as an essential constituent of cytochrome P-450, is required Table 7 . Effect of the addition ofglycine, 5-aminolaevulinate or protoporphyrin on the incorporation of "Fe into haem by liver homogenates
The animals (three rats in each group) were starved for 24h, then given 3,5-diethoxycarbonyl- Wilt (1968) for the stimulation by haem of haemoglobin synthesis in vitro. Secondly, the results obtained in the present work with phenylbutazone indicate that a considerable accumulation of cytochrome P-450 can be observed without great changes in either 5-aminolaevulinate synthetase activity or rate of haem synthesis in vitro. Finally, it has been found (De Matteis, 1971a ) that the administration of 5-aminolaevulinate or haem to either normal or phenylbutazone-treated rats did not increase the cytochrome P-450 above the concentrations observed in the respective controls (which had not been given haem or its precursor); this also suggests that an increased supply of 5-aminolaevulinate and haem is probably not sufficient in itself to stimulate the formation of the cytochrome.
Mechanism(s) of stimulation of 5-aminolaevulinate synthetase by drugs A distinction must be made between the large increase in 5-aminolaevulinate synthetase activity observed in the drug-induced hepatic porphyrias of the experimental animal and the small stimulation of the enzyme frequently observed after drugs without a significant accumulation of porphyrins in the liver.
The latter is of common occurrence after administration of many drugs that increase the size of the liver and the concentration of cytochrome P-450 in the liver microsomal fraction (Wada et al., 1968; Abbritti & De Matteis, 1971-72) . For example, in the present work phenylbutazone marginally increased Vol. 126 the activity of the enzyme and slightly stimulated the incorporation of 59Fe into haem by liver slices, a finding which also suggested a small stimulation of the production of haem precursors. It is possible that the small effect exercised by so many drugs on 5-aminolaevulinate synthetase activity is in some way related to their property of increasing the. size of the liver and the activity ofmany liver enzymes (De Matteis, 1971a) . Or it is possible that by increasing the amount of the cytochrome P-450 apoprotein these drugs may increase haem utilization and therefore also, to a small extent, the rate of haem and 5-aminolaevulinate production.
A mechanism ofthis type, involving either a geteral alteration of liver protein metabolism or a concerted increase in the production of the haem and protein moieties of cytochrome P-450, is not sufficient, however, to explain why with some drugs the increase in 5-aminolaevulinate synthetase becomes very marked and is accompanied by the appearance of porphyria. The experiments conducted here with 3,5-diethoxycarbonyl-1,4-dihydrocollidine and phenylbutazone clearly indicate that there are some drugs that are powerful inducers of 5-aminolaevulinate synthetase or of cytochrome P-450 but not of both; this finding, and the observation that when the two drugs were given together both effects were observed, strongly suggests that marked stimulation of 5-aminolaevulinate synthetase and porphyria on the one hand'and increase in cytochromg P-450 and drug-metabolizing enzymes on the other result from two different actions. The same is probably true for the increase in liver size and protein content, which can also be dissociated from the appearance of porphyria (see also De Matteis, 1966) . Therefore, for Meyer & Marver, 1971 ) and of certain porphyrogenic drugs chemically related to 2-allyl-2-isopropylacetamide (Abbritti & De Matteis, 1971-72) . A loss of microsomal cytochrome P-450 and haem has also been observed in rabbits and mice after administration of either 3,5-diethoxycarbonyl-1,4-dihydrocollidine or 2-allyl-2-isopropylacetamide and also after feeding with another porphyria-inducing compound, griseofulvin (Wada et al., 1968; Waterfield et al., 1969 Meyer & Marver, 1971 ) and related drugs (Abbritti & De Matteis, 1971-72) . For 3,5-diethoxycarbonyl-1,4-dihydrocollidine previous findings and the results of the present work suggest that the drug inhibits the synthesis ofliver haem. Onisawa & Labbe (1963) have reported an inhibition of the synthesis of haem in the liver of mice treated for several days with this drug and Tephly et al. (1971) have described an inhibition of the ferrochelatase in the liver of rats 24h after a single dose. In our experiments, the activity of the mitochondrial chelatase was found to be inhibited as early as lh after administration of 3,5-diethoxycarbonyl-1,4-dihydrocollidine, when the 5-aminolaevulinate synthetase activity was still normal or just starting to rise; so it is possible that inhibition of the conversion of protoporphyrin into haem may not only explain the very marked accumulation of protoporphyrin in the liver, which is characteristic of this type of hepatic porphyria (Onisawa & Labbe, 1963) , but also represent the primary lesion responsible for the stimulation of 5-aminolaevulinate synthetase and the overproduction of porphyrins.
The experiments on the incorporation of 59Fe into haem in vitro ( Fig. 2 and Table 7 ) require further comment. From the results obtained with control homogenates it can be concluded that the rate of haem synthesis in normal liver is primarily controlled by the supply of 5-aminolaevulinate and protoporphyrin and not by the activity of the chelatase, which is in large excess; this conclusion is in agreement with the concept that 5-aminolaevulinate synthetase is the rate-limiting step in the pathway of haem biosynthesis (Granick, 1966) . The finding that protoporphyrin was much more effective than 5-aminolaevulinate in stimulating the incorporation of s9Fe into haem by liver homogenates from control animals suggests, on the other hand, that under conditions where the supply of 5-aminolaevulinate becomes excessive one or more of the enzymes of the pathway concerned with its further metabolism to protoporphyrin may become rate-limiting. The results obtained with porphyric homogenates are best explained by the rapid inhibition of the chelatase and by the accumulation of protoporphyrin in the liver, which are observed after treatment with 3,5-diethoxycarbonyl-1,4-dihydrocollidine; under these conditions the supply ofprotoporphyrin is not limiting and the rate of haem synthesis appears to be determined primarily by the activity of the chelatase.
Potentiation by phenylbutazone ofporphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine
The reason why administration of phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine together resulted in a greater stimulation of 5-aminolaevulinate synthetase and in a more marked degree of porphyria than observed with 3,5-diethoxycarbonyl-1,4-dihydrocollidine alone is not known. It will be noted that although the effects of the two drugs given together on liver size (and total protein content) were roughly equal to the sum of the effects found when either drug was administered individually, this was not the case for the stimulation of 5-aminolaevulinate synthetase and 5-aminolaevulinate dehydratase and for the accumulation in the liver of 5-aminolaevulinate and porphyrins, where a considerably greater effect was noted. This observation, and the finding that when the two drugs were given together the inhibition of the chelatase and the decrease in cytochrome P-450 were not greater than when 3,5-diethoxycarbonyl-1,4-dihydrocollidine was given on its own, suggest that stimulation of 5-aminolaevulinate synthetase by the latter drug and potentiation of this effect by phenylbutazone may be through different mechanisms. Perhaps 3,5-diethoxycarbonyl-1,4-dihydrocollidine acts by inhibiting the synthesis of liver haem and by lowering the concentration of haem available for control of 5-aminolaevulinate synthetase, whereas phenylbutazone, by causing an accumulation of cytochrome P-450 apoprotein, stimulates haem utilization and thereby decreases the concentration of this 'regulatory' haem still further. Alternatively, the potentiation by phenylbutazone of porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine may be explained by the marked effect on liver protein metabolismexhibited by the former drug. If the stimulation of 5-aminolaevulinate synthetase by 3,5-diethoxycarbonyl-1,4-dihydrocollidine involves accumulation of enzyme protein (Granick, 1966 ) (rather than, or as well as, activation of an already existing enzyme), then it is possible that this response might be further increased under conditions in which the overall rate of liver protein accumulation is also increased.
Like phenylbutazone, thiopentone [5-ethyl-5-(1-methylbutyl) thiobarbituric acid] and phenobarbitone (5-ethyl-5-phenylbarbituric acid) can also potentiate the porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (F. De Matteis, unpublished work). These findings may be ofrelevance to the exacerbation of human genetic porphyria caused by barbiturates and other drugs.
